nasdaq:nuro
|
56402
|
Mar 23rd, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
63.00
|
Open
|
|
Mar 23rd, 2024 12:00AM
|
Mar 23rd, 2024 07:10PM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|
nasdaq:nuro
|
56402
|
Mar 22nd, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
63.00
|
Open
|
|
Mar 21st, 2024 11:51PM
|
Mar 22nd, 2024 06:58PM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|
nasdaq:nuro
|
56402
|
Mar 21st, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
63.00
|
Open
|
|
Mar 21st, 2024 12:04AM
|
Mar 21st, 2024 05:42PM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|
nasdaq:nuro
|
56402
|
Mar 20th, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
64.00
|
Open
|
|
Mar 20th, 2024 12:45AM
|
Mar 20th, 2024 07:43PM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|
nasdaq:nuro
|
56402
|
Mar 19th, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
64.00
|
Open
|
|
Mar 18th, 2024 11:39PM
|
Mar 19th, 2024 06:15PM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|
nasdaq:nuro
|
56402
|
Mar 18th, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
64.00
|
Open
|
|
Mar 18th, 2024 12:01AM
|
Mar 18th, 2024 07:27PM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|
nasdaq:nuro
|
56402
|
Mar 16th, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
64.00
|
Open
|
|
Mar 15th, 2024 11:30PM
|
Mar 16th, 2024 07:14PM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|
nasdaq:nuro
|
56402
|
Mar 15th, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
64.00
|
Open
|
|
Mar 15th, 2024 01:17AM
|
Mar 15th, 2024 09:04AM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|
nasdaq:nuro
|
56402
|
Mar 14th, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
64.00
|
Open
|
|
Mar 13th, 2024 11:29PM
|
Mar 14th, 2024 12:26PM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|
nasdaq:nuro
|
56402
|
Mar 13th, 2024 12:00AM
|
NeuroMetrix, Inc.
|
3.4K
|
64.00
|
Open
|
|
Mar 12th, 2024 11:24PM
|
Mar 13th, 2024 10:56AM
|
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.
The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
NeuroMetrix markets the following products:
DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com.
ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com.
Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
|
Open
|
Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering
|
Open
|
4b Gill St
|
Woburn
|
Massachusetts
|
US
|
01801
|
|
NeuroMetrix
|
|
Health Care Equipment & Services
|